AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2023

Mar 3, 2023

35599_dirs_2023-03-03_ed7ee6f4-215f-47fc-8c78-8c141554a673.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-03-03

Reporting Person: RALLIS CHRIS A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-03	Common Shares	M	4166	$2.40	Acquired	34184	Direct
2023-03-03	Common Shares	F	2177	$9.09	Disposed	32077	Direct

Footnotes

F1: Represents options granted April 3, 2013, with a $2.40 USD strike price and expiration of April 3, 2023.

F2: Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,166 shares from an April 3, 2013 grant.